- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 8 residues within 4Å:- Chain A: L.134, L.137, A.138, A.141, F.296, V.362, S.365, I.366
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.296, A:F.296, A:I.366, A:I.366
CLR.4: 15 residues within 4Å:- Chain A: W.152, M.153, L.156, I.160, L.162, L.165, W.193, L.196, W.217, F.221, L.224, L.271
- Chain C: Y.95, L.96, V.99
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:W.152, A:L.156, A:I.160, A:L.165, A:W.193, A:L.224, C:L.96
CLR.8: 8 residues within 4Å:- Chain D: L.134, L.137, A.138, A.141, F.296, V.362, S.365, I.366
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:F.296, D:F.296, D:I.366, D:I.366
CLR.9: 15 residues within 4Å:- Chain B: Y.95, L.96, V.99
- Chain D: W.152, M.153, L.156, I.160, L.162, L.165, W.193, L.196, W.217, F.221, L.224, L.271
8 PLIP interactions:7 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:W.152, D:L.156, D:I.160, D:L.162, D:L.165, D:W.193, D:L.224, B:L.96
- 2 x 01: (2R)-1-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5E,8E,11E,13E)-icosa-5,8,11,13-tetraenoate
01.5: 28 residues within 4Å:- Chain A: L.142, L.145, I.253, R.254, G.255, L.257, G.258, K.259, W.260, L.262, M.263, T.266, I.267, N.294, I.295, Y.298, K.310
- Chain C: I.94, Y.95, V.98, A.101, L.102, Y.105, A.160, Q.161, R.163, W.164, Q.167
26 PLIP interactions:6 interactions with chain C, 20 interactions with chain A- Hydrophobic interactions: C:I.94, C:V.98, C:A.101, C:Y.105, A:L.142, A:L.145, A:L.145, A:K.259, A:W.260, A:L.262, A:M.263, A:I.267
- Hydrogen bonds: C:Q.167, A:I.253, A:R.254, A:G.255, A:K.259, A:W.260, A:N.294, A:Y.298, A:Y.298, A:Y.298
- Salt bridges: C:R.163, A:K.259, A:K.259, A:K.310
01.10: 28 residues within 4Å:- Chain B: I.94, Y.95, V.98, A.101, L.102, Y.105, A.160, Q.161, R.163, W.164, Q.167
- Chain D: L.142, L.145, I.253, R.254, G.255, L.257, G.258, K.259, W.260, L.262, M.263, T.266, I.267, N.294, I.295, Y.298, K.310
26 PLIP interactions:6 interactions with chain B, 20 interactions with chain D- Hydrophobic interactions: B:I.94, B:V.98, B:A.101, B:Y.105, D:L.142, D:L.145, D:L.145, D:K.259, D:W.260, D:L.262, D:M.263, D:I.267
- Hydrogen bonds: B:Q.167, D:I.253, D:R.254, D:G.255, D:K.259, D:W.260, D:N.294, D:Y.298, D:Y.298, D:Y.298
- Salt bridges: B:R.163, D:K.259, D:K.259, D:K.310
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schrecker, M. et al., Structural basis of ClC-3 inhibition by TMEM9 and PI(3,5)P 2. Biorxiv (2025)
- Release Date
- 2025-04-02
- Peptides
- H(+)/Cl(-) exchange transporter 3: AD
Proton-transporting V-type ATPase complex assembly regulator TMEM9: BC - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
CB
DC
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 2 x 01: (2R)-1-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5E,8E,11E,13E)-icosa-5,8,11,13-tetraenoate
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schrecker, M. et al., Structural basis of ClC-3 inhibition by TMEM9 and PI(3,5)P 2. Biorxiv (2025)
- Release Date
- 2025-04-02
- Peptides
- H(+)/Cl(-) exchange transporter 3: AD
Proton-transporting V-type ATPase complex assembly regulator TMEM9: BC - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
CB
DC
B - Membrane
-
We predict this structure to be a membrane protein.